doxylamine succinate and pyridoxine hydrochloride

Generic: doxylamine succinate and pyridoxine hydrochloride

Labeler: actavis pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxylamine succinate and pyridoxine hydrochloride
Generic Name doxylamine succinate and pyridoxine hydrochloride
Labeler actavis pharma, inc.
Dosage Form TABLET, DELAYED RELEASE
Routes
ORAL
Active Ingredients

doxylamine succinate 10 mg/1, pyridoxine hydrochloride 10 mg/1

Manufacturer
Actavis Pharma, Inc.

Identifiers & Regulatory

Product NDC 0591-2132
Product ID 0591-2132_a51f5dfd-c4ff-4fea-8a7c-1fc058cd7c11
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205811
Listing Expiration 2026-12-31
Marketing Start 2019-06-21

Pharmacologic Class

Classes
analogs/derivatives [chemical/ingredient] antihistamine [epc] histamine receptor antagonists [moa] vitamin b 6 [chemical/ingredient] vitamin b6 analog [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05912132
Hyphenated Format 0591-2132

Supplemental Identifiers

RxCUI
1375948
UNII
V9BI9B5YI2 68Y4CF58BV

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxylamine succinate and pyridoxine hydrochloride (source: ndc)
Generic Name doxylamine succinate and pyridoxine hydrochloride (source: ndc)
Application Number ANDA205811 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01)
source: ndc

Packages (1)

0591-2132-01 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01)

Ingredients (2)

doxylamine succinate (10 mg/1) pyridoxine hydrochloride (10 mg/1)

Linked Drug Pages (1)

Doxylamine succinate and pyridoxine hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a51f5dfd-c4ff-4fea-8a7c-1fc058cd7c11", "openfda": {"unii": ["V9BI9B5YI2", "68Y4CF58BV"], "rxcui": ["1375948"], "spl_set_id": ["3670d66e-c1e4-42ce-8760-c3d5accad925"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, DELAYED RELEASE in 1 BOTTLE (0591-2132-01)", "package_ndc": "0591-2132-01", "marketing_start_date": "20190621"}], "brand_name": "Doxylamine succinate and pyridoxine hydrochloride", "product_id": "0591-2132_a51f5dfd-c4ff-4fea-8a7c-1fc058cd7c11", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Analogs/Derivatives [Chemical/Ingredient]", "Antihistamine [EPC]", "Histamine Receptor Antagonists [MoA]", "Vitamin B 6 [Chemical/Ingredient]", "Vitamin B6 Analog [EPC]"], "product_ndc": "0591-2132", "generic_name": "Doxylamine succinate and pyridoxine hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxylamine succinate and pyridoxine hydrochloride", "active_ingredients": [{"name": "DOXYLAMINE SUCCINATE", "strength": "10 mg/1"}, {"name": "PYRIDOXINE HYDROCHLORIDE", "strength": "10 mg/1"}], "application_number": "ANDA205811", "marketing_category": "ANDA", "marketing_start_date": "20190621", "listing_expiration_date": "20261231"}